Earnings call: NRx Pharmaceuticals eyes ketamine alternative for depression By Investing.com
[ad_1] NRx Pharmaceuticals, Inc. (NRXP) announced progress in developing its novel drug NRX-101 for treating severe depression and suicidal ideation during its Fourth Quarter and...
Pro Research: Wall Street delves into Vertex Pharmaceuticals By Investing.com
[ad_1] Explore Wall Street’s expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon. Dive deeper into the financial world...
Ars Pharmaceuticals CEO sells over $900k in company stock By Investing.com
[ad_1] © Reuters. In a recent transaction, Richard E. Lowenthal, President and CEO of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY), has sold a significant amount of company...
ASLAN Pharmaceuticals announces $5 million offering By Investing.com
[ad_1] © Reuters. SAN MATEO, Calif. and SINGAPORE – ASLAN Pharmaceuticals Ltd. (NASDAQ:ASLN), a biopharmaceutical company specializing in immunology, has announced a registered direct offering...
Rigel Pharmaceuticals names new Chief Medical Officer By Investing.com
[ad_1] © Reuters. SOUTH SAN FRANCISCO, Calif. – Rigel (NASDAQ:) Pharmaceuticals, Inc. (NASDAQ:RIGL) has announced the appointment of Lisa Rojkjaer, M.D., as its new Executive...
Earnings call: Agios Pharmaceuticals outlines robust pipeline and financial health By Investing.com
[ad_1] © Reuters. Agios Pharmaceuticals Inc. (AGIO) recently shared promising updates during its earnings call, highlighting significant progress in its clinical development programs for mitapivat...
Phathom Pharmaceuticals gains Express Scripts formulary placement By Investing.com
[ad_1] © Reuters. FLORHAM PARK, N.J. – Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), a biopharmaceutical company, has announced that its drug VOQUEZNA (vonoprazan) tablets are now included...
Tel Aviv stock indices fall, Teva Pharmaceuticals hits annual high By Investing.com
[ad_1] © Sivan Farag, Teva PR TEL AVIV – In the latest market movements on the Tel Aviv Stock Exchange, key indices have experienced a...
Apellis Pharmaceuticals stock just tumbled. Here’s why By Investing.com
[ad_1] © Reuters. Apellis Pharmaceuticals (APLS) stock just tumbled. Here’s why Apellis Pharma (APLS) stock experienced a sharp pre-market decline following news that it anticipates...
Pro Research: Wall Street delves into Alnylam Pharmaceuticals By Investing.com
[ad_1] © Reuters Explore Wall Street’s expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon. Enhance your investment strategy...